Analysis of PFS showed that CD74 levels were predictive of unfavorable prognosis in GBM, LGG, and THYM but were protective in ACC, BLCA, BRCA, HNSC, LUAD, MESO, SKCM, and UCEC (Figs. 2F, S4–S6). The gene discussed is CD74; the disease is glioblastoma.